Literature DB >> 4188300

Peritoneal dialysis in maple syrup urine disease.

S E Sallan, D Cottom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4188300     DOI： 10.1016/s0140-6736(69)90961-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Management of maple syrup urine disease in Canada. Committee for improvement of Hereditary Disease Management.

Authors: 
Journal:  Can Med Assoc J       Date:  1976-11-20       Impact factor: 8.262

2.  Peritoneal dialysis in maple-syrup-urine disease: studies on branched-chain amino and keto acids.

Authors:  U Wendel; K Becker; H Przyrembel; M Bulla; C Manegold; A Mench-Hoinowski; U Langenbeck
Journal:  Eur J Pediatr       Date:  1980-06       Impact factor: 3.183

3.  Hudson memorial lecture. Neonatal management of organic acidurias. Clinical update.

Authors:  J M Saudubray; H Ogier; C Charpentier; E Depondt; F X Coudé; A Munnich; G Mitchell; F Rey; J Rey; J Frézal
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

4.  Maple syrup urine disease: treatment of the acutely ill newborn.

Authors:  G Hammersen; L Wille; H Schmidt; P Lutz; H Bickel
Journal:  Eur J Pediatr       Date:  1978-10-12       Impact factor: 3.183

5.  Successful repair and postoperative management of tetralogy of Fallot in a patient with maple syrup urine disease.

Authors:  M Fukutomi; S Kitamura; K Kawachi; T Tsuji; K Hashimoto; A Yoshioka
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

6.  Comparison of temporary and permanent catheters for acute peritoneal dialysis.

Authors:  S N Wong; D F Geary
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

Review 7.  Animal models of maple syrup urine disease.

Authors:  K J Skvorak
Journal:  J Inherit Metab Dis       Date:  2009-03-09       Impact factor: 4.982
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.